MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072547 A) filed by Janssen Biotech, Inc. on June 11, 2026, for Manufacturing Systems, Methods, And Ai Models For Car T Drug Products With Improved Safety.

Inventors include Magge Ranganatha, Arjun; Javidi, Alex; Lu, Hoang; Henckels, Eric Number; Ciccone, Daniel; Morris, Donald; and Bowden, Robert.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Systems and methods are disclosed for predicting a vector copy number (VCN) per transduced cell of a patient-specific CAR T drug product for a target patient. An example method includes: receiving quantitative data for a set of VCN parameters; generating an input feature vector comprising the quantitative data for the set of VCN parameters; and applying, into a trained machine learning model, the input feature vector to generate an output feature vector predicting the VCN per transduced cell of the patient-specific CAR T drug product for the target patient.

Disclaimer: Curated by HT Syndication.